Recent U.S. government actions, including the May 2025 Executive Order entitled, “Delivering Most-Favored Nation Prescription Drug Pricing to American Patients,” which, among various proposals, seeks to establish ‘most-favored-nation’ pricing for certain prescription drugs, could significantly impact our business.
